<DOC>
	<DOCNO>NCT00561626</DOCNO>
	<brief_summary>Rationale : The prevalence metabolic syndrome strongly increase developed country . The role small intestine seem important development metabolic syndrome . Although know high-fat Western-style diet deleterious effect ( post-prandial ) lipidemia glucose homeostases , effect diet small intestine know . To elucidate role small intestine early development metabolic syndrome , effect high-fat ( HF ) low-fat ( LF ) diet examine gene expression small intestine early biomarkers blood healthy subject . Objective : The objective study compare healthy subject effect HF diet ( 40 En % fat ) LF diet ( 20 En % fat ) early biomarkers parameter metabolic stress blood expression gene small intestine . Additional research objective : - To compare diet-induced change transcriptome profile small intestine easily accessible peripheral blood mononuclear cell ( PBMC ) - To establish effect HF LF diet basal gut permeability chenodeoxycholic acid ( CDCA ) load ( second hit ) . Study design : Randomised crossover design . The duration experimental period ( HF LF diet ) 28 day , separated wash period least 3 week . At day 21 intervention period postprandial test perform duodenum biopsy take . At day 25 28 intervention period , respectively , basal gut permeability gut permeability CDCA load determine sugar recovery test . Study population : Ten healthy men age 18-60 year , without history gastrointestinal disorder complaint . Intervention : Subjects consume random order : - HF diet ( 40 En % fat , 45 En % carbohydrates 15 En % protein ) - LF diet ( 20 En % fat , 65 En % carbohydrates 15 En % protein ) Primary study parameters/endpoints : Potential early biomarkers metabolic syndrome blood gene expression profile small intestine . Secondary study parameters/endpoints : Parameters metabolic syndrome blood , gene expression profile PBMC gut permeability .</brief_summary>
	<brief_title>Effects High-fat Low-fat Diet Gut</brief_title>
	<detailed_description />
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>age 18 65 year body mass index ( BMI ) 18 30 kg/m2 BMI ≤ 18 ≥ 25 kg/m2 Smoking Serum Total cholesterol &gt; 8.0 mmol/L Fasting glucose &gt; 7.0 mmol/L Use medication Active cardiovascular disease like congestive heart failure recent ( &lt; 6 month ) event ( acute myocardial infarction , CVA ) Gastrointestinal disease ( like celiac disease , inflammatory bowel disease , irritable bowel disease food allergy ) history gastrointestinal disorder complaint Preexisting gallbladder disease Diabetes mellitus Familial hypercholesterolemia Severe medical condition might interfere study epilepsy , asthma , COPD rheumatoid arthritis . Unstable body weight ( weight gain loss &gt; 3 kg past three month ) Impairment renal function , evidence increase serum creatinine &gt; 150 mmol/L Hepatic disease manifest ALT , AST , GGT , total bilirubin ALP &gt; 2 time upper limit normal CRP value &gt; 8.0 mg/mL Abuse drug and/or alcohol Participation another biomedical study within 1 month prior start study Having donate blood ( blood donor ) within 1 month prior start study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2008</verification_date>
</DOC>